A new clinical trial led by QIMR Berghofer, in collaboration with University of Sunshine Coast Clinical Trials Network has found a medication currently used for some blood disorders could help the ...

Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine Interferon is a key player in the innate immune response.

McMaster University researchers have found not only how some viral infections cause severe tissue damage, but also how to reduce that damage. They have discovered how Type I interferon (IFN) stops the ...

Advances in the treatment of gastroenteropancreatic poorly differentiated neuroendocrine carcinoma at our hospital. This is an ASCO Meeting Abstract from the 2024 ASCO Gastrointestinal Cancers ...

When interferons were first discovered in the 1950s, it was hoped that these naturally occurring chemicals could do for viruses what penicillin did for bacterial infections. Although that wish didn't ...

In a recent study posted to the bioRxiv* preprint server, researchers assessed the roles of the interferon (IFN) regulatory factors (IRFs): IRF1, IRF3, and IRF7 in infections by human coronaviruses ...